Anna Grimaldi
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Microbiology top 5%
Papers in
-
- MicroRNA in disease regulation 13
- Cancer-related molecular mechanisms research 6
- Cancer, Hypoxia, and Metabolism 4
- Oncology 17
- Co-authors
- Michele Caraglia (26 shared papers)Marco Salvatore (22 shared papers)Mariarosaria Incoronato (15 shared papers)Silvia Zappavigna (9 shared papers)Gabriella Misso (12 shared papers)Angela Lombardi (10 shared papers)Amalia Luce (4 shared papers)Peppino Mirabelli (7 shared papers)
- Journals
- International Journal of Molecular Sciences (5 papers)Scientific Reports (5 papers)Cancer Biology & Therapy (4 papers)PLoS ONE (3 papers)Journal of Cellular Physiology (3 papers)
- Partner nations
- ItalyUnited StatesCzechia
In The Last Decade
Anna Grimaldi
89 papers receiving 3.1k citations
Anna Grimaldi's Hit Papers
Peers
Comparison fields: 5 of 162
- Cancer Research 578
- Microbiology 19
- Oncology 446
- Molecular Biology 1.1k
- Biomaterials 206
Countries citing papers authored by Anna Grimaldi
This map shows the geographic impact of Anna Grimaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Grimaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Grimaldi more than expected).
Fields of papers citing papers by Anna Grimaldi
This network shows the impact of papers produced by Anna Grimaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Grimaldi. The network helps show where Anna Grimaldi may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Grimaldi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mitochondria as playmakers of apoptosis, autophagy and senescence Hit paper breakdown → | 2019 | 452 |
| 2 | Anti-Inflammatory Drugs as Anticancer Agents Hit paper breakdown → | 2020 | 317 |
| 3 | Biobanking in health care: evolution and future directions Hit paper breakdown → | 2019 | 278 |
| 4 | 2017 | 116 | |
| 5 | 2012 | 113 | |
| 6 | 2014 | 102 | |
| 7 | 2013 | 81 | |
| 8 | 2014 | 75 | |
| 9 | 2017 | 59 | |
| 10 | 2016 | 58 | |
| 11 | 2015 | 57 | |
| 12 | 2021 | 57 | |
| 13 | 2017 | 57 | |
| 14 | 2012 | 56 | |
| 15 | 2019 | 54 | |
| 16 | 2014 | 48 | |
| 17 | 2016 | 45 | |
| 18 | 2017 | 45 | |
| 19 | 2019 | 44 | |
| 20 | 2018 | 44 |
About Anna Grimaldi
Anna Grimaldi is a scholar working on Cancer Research, Oncology, Molecular Biology, Epidemiology and Biomaterials, having authored 93 papers that have together received 3.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (13 papers), Cancer-related molecular mechanisms research (6 papers), RNA Interference and Gene Delivery (6 papers), Nanoparticle-Based Drug Delivery (6 papers), Autophagy in Disease and Therapy (5 papers), Extracellular vesicles in disease (5 papers), Circular RNAs in diseases (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Cancer Research (578 citations), Microbiology (19 citations), Oncology (446 citations), Molecular Biology (1.1k citations) and Biomaterials (206 citations). Anna Grimaldi has collaborated with scholars based in Italy, United States and Czechia. Frequent co-authors include Michele Caraglia, Marco Salvatore, Mariarosaria Incoronato, Silvia Zappavigna, Gabriella Misso, Angela Lombardi, Amalia Luce, Peppino Mirabelli, Andrea Soricelli and Carlo Irace. Their work appears in journals such as International Journal of Molecular Sciences, Scientific Reports, Cancer Biology & Therapy, PLoS ONE and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.